<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula</h2>
    <div class="badge">2025-09-08T10:45:00+00:00</div>
    <ul>
      <li>Pfizer Disclosure Notice The information contained in this release is as of September 8, 2025.</li>
<li>at 1-800-438-1985 or www.pfizersafetyreporting.com.</li>
<li>For 175 years, we have worked to make a difference for all who rely on us.</li>
<li>INDICATION AND IMPORTANT SAFETY INFORMATION INDICATION COMIRNATY (COVID-19 VACCINE, mRNA) is a vaccine to protect against coronavirus disease 2019 (COVID-19).</li>
<li>You should review the risks and uncertainties described under the heading &quot;Risk Factors&quot; in BioNTech&#x27;s Report on Form 6-K for the period ended June 30, 2025, and in subsequent filings made by BioNTech with the SEC, which</li>
<li>Prior to receiving the LP.8.1-adapted COVID-19 vaccine 2025-2026 Formula, all participants had received the KP.2-adapted COVID-19 vaccine at least six months prior to enrollment and had not received any other COVID-19 va</li>
<li>A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in its subsequent reports on Form 10-Q, including in the sections there</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Pfizer%20and%20BioNTech%20Announce%20Topline%20Data%20Demonstrating%20Robust%20Immune%20Response%20With%20Their%20LP.8.1-Adapted%20COVID-19%20Vaccine%202025-2026%20Formula%0A%E2%80%A2%20Pfizer%20Disclosure%20Notice%20The%20information%20contained%20in%20this%20release%20is%20as%20of%20September%208%2C%202025.%0A%E2%80%A2%20at%201-800-438-1985%20or%20www.pfizersafetyreporting.com.%0A%E2%80%A2%20For%20175%20years%2C%20we%20have%20worked%20to%20make%20a%20difference%20for%20all%20who%20rely%20on%20us.%0A%E2%80%A2%20INDICATION%20AND%20IMPORTANT%20SAFETY%20INFORMATION%20INDICATION%20COMIRNATY%20%28COVID-19%20VACCINE%2C%20mRNA%29%20is%20a%20vaccine%20to%20protect%20against%20coronavirus%20disease%202019%20%28COVID-19%29.%0A%E2%80%A2%20You%20should%20review%20the%20risks%20and%20uncertainties%20described%20under%20the%20heading%20%22Risk%20Factors%22%20in%20BioNTech%27s%20Report%20on%20Form%206-K%20for%20the%20period%20ended%20June%2030%2C%202025%2C%20and%20in%20subsequent%20filings%20made%20by%20BioNTech%20with%20the%20SEC%2C%20which%0A%E2%80%A2%20Prior%20to%20receiving%20the%20LP.8.1-adapted%20COVID-19%20vaccine%202025-2026%20Formula%2C%20all%20participants%20had%20received%20the%20KP.2-adapted%20COVID-19%20vaccine%20at%20least%20six%20months%20prior%20to%20enrollment%20and%20had%20not%20received%20any%20other%20COVID-19%20va%0A%E2%80%A2%20A%20further%20description%20of%20risks%20and%20uncertainties%20can%20be%20found%20in%20Pfizer%E2%80%99s%20Annual%20Report%20on%20Form%2010-K%20for%20the%20fiscal%20year%20ended%20December%2031%2C%202024%20and%20in%20its%20subsequent%20reports%20on%20Form%2010-Q%2C%20including%20in%20the%20sections%20there&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fpfizer-and-biontech-announce-topline-data-demonstrating-robust-immune-response-w%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/pfizer-biontech-announce-topline-data-104500046.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>